Richard S. Levy - 14 May 2025 Form 4/A - Amendment Insider Report for Protara Therapeutics, Inc. (TARA)

Reporting relationship: Director
Issuer ticker: TARA
Reported as of: 14 May 2025
Net transaction value: +$63,800
SEC form: 4/A - Amendment
Accepted by SEC: 19 May 2025, 16:10:10 UTC
Original report date: 16 May 2025
Prior SEC filing: 11 Apr 2025
Next SEC filing: 05 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ Mary Grendell, Attorney-in-fact

Key filing fact

Richard S. Levy filed Form 4/A - Amendment for Protara Therapeutics, Inc. (TARA) on 19 May 2025.

Key facts

This page summarizes Richard S. Levy's Form 4/A - Amendment filing for Protara Therapeutics, Inc. (TARA).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 19 May 2025, 16:10.

Change

Previous filing in this sequence was filed on 11 Apr 2025.
Current net transaction value: +$63,800.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reporting Owners (1)

CIK 0001454983 Primary reporting owner

Levy Richard S

Relationship: Director
Address: C/O PROTARA THERAPEUTICS, INC., 345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK
Signature: /s/ Mary Grendell, Attorney-in-fact
Signature date: 19 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TARA transaction

Common Stock

Purchase

Transaction value: $63,800
Shares: +20,000
Change %: +65%
Price: $3.19
Shares after: 51,000
Date: 14 May 2025
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.15 to $3.22, inclusive. The reporting person undertakes to provide to TARA, any security holder of TARA, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC remarks

This amendment is to revise the footnote above to reflect that the transactions that are the subject of this Form 4 were purchases, not sales, of shares of TARA.